DexCom Net Income Trend

DXCM -- USA Stock  

Earning Report: November 6, 2019  

This module enables investors to look at DexCom various fundamental indicators over time in order to gain insight into the company future performance. Macroaxis historical fundamental analysis tools allow evaluation of not only typical financial statement drivers such as Direct Expenses of 244.3 M, Cost of Revenue of 62.1 M or Gross Profit of 663.9 M, but also many exotic indicators such as Long Term Debt to Equity of 1.0091, PPandE Turnover of 6.1878 or Receivables Turnover of 7.4291. This module is a perfect complement to use when analyzing DexCom Valuation or Volatility. It can also complement various DexCom Technical models. Additionally see analysis of DexCom Correlation with competitors.

DexCom Net Income Marginal Breakdown

Showing smoothed Net Income of DexCom with missing and latest data points interpolated. Net income is one of the most important fundamental items in finance. It plays a large role in DexCom financial statement analysis. It represents the amount of money remaining after all of DexCom operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. The portion of profit or loss for the period; net of income taxes; which is attributable to the parent after the deduction of [NetIncNCI] from [ConsolInc]; and before the deduction of [PrefDivIS].
View

(170.5 M)

          10 Years Trend
Decreasing
Very volatile
 Net Income 
      Timeline 

DexCom Regression Statistics

Arithmetic Mean(31,159,124)
Geometric Mean 12,491,909
Coefficient Of Variation(178.84)
Mean Deviation 39,213,625
Median(7,708,029)
Standard Deviation 55,724,009
Range 163,562,774
R Value(0.11)
R Squared 0.011329
Significance 0.74
Slope(1,644,975)

DexCom Net Income Over Time

2009 (7,708,029) 
2018 (6,937,226) 
2019 (170,500,000) 

Other Fundumenentals of DexCom

Search macroaxis.com